What's new

Q&A clinic on web-based electronic Application Form (eAF) functionalities for CAPs and non-CAPs variations, Online, European Medicines Agency, Amsterdam, the Netherlands, from 8 July 2025, 10:00 (CEST) to 8 July 2025, 11:00 (CEST)

Q&A clinic on web-based electronic Application Form (eAF) functionalities for CAPs and non-CAPs variations, Online, European Medicines Agency, Amsterdam, the Netherlands, from 8 July 2025, 10:00 (CEST) to 8 July 2025, 11:00 (CEST)

Jun 25, 2025 - 11:10
 0
Q&A clinic on web-based electronic Application Form (eAF) functionalities for CAPs and non-CAPs variations, Online, European Medicines Agency, Amsterdam, the Netherlands, from 8 July 2025, 10:00 (CEST) to 8 July 2025, 11:00 (CEST)
Q&A clinic on web-based electronic Application Form (eAF) functionalities for CAPs and non-CAPs variations, Online, European Medicines Agency, Amsterdam, the Netherlands, from 8 July 2025, 10:00 (CEST) to 8 July 2025, 11:00 (CEST)
Read More

Tags:

Previous Article

EMEA-000534-PIP03-17-M01

Next Article

Lixin Energy to Invest RMB 529 Million in 200MW/800MWh Grid-Forming Standalone E...

Related Posts

NovoSeven (eptacog alfa)

NovoSeven (eptacog alfa)

May 12, 2025  0

Code of conduct of the European Medicines Agency

Jun 19, 2025  0

Opinion/decision on a Paediatric investigation plan (PIP): Supemtek Tetra (previously Supemtek), recombinant Influenza Hemagglutinin-strain A (H1N1 subtype),recombinant Influenza Hemagglutinin-strain A (H3N2 subtype),recombinant Influenza Hemagglutinin-strain B (Victoria lineage),recombinant Influenza Hemagglutinin-strain B (Yamagata lineage) (RIV4), decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infections and infestations, PIP number: P/0218

Opinion/decision on a Paediatric investigation plan (PI...

Jun 24, 2025  0